Summary of second plenary at NACFC:
https://www.cff.org/CF-Community-Bl...-CF-Community-Effort-to-Advance-CF-Therapies/
Emphasis on importance of clinical trial participation:
"...However, as exciting as it to have the most clinical trials for CF underway ever, enrollment is a serious challenge, Dr. Flume said. With only 33,000 people with CF in the United States, it is difficult to recruit enough people who meet all the eligibility criteria for a trial.".....
"In an effort to expand the pool of people who can enroll in trials and accelerate drug development, the CF Foundation is also focusing on helping the performance of clinical trials in the United Kingdom, Europe and Australia. These countries have diverse concentrations of people with specific CF mutations, making it easier to find people who are eligible for certain trials...The European Cystic Fibrosis Society region alone represents people with 1,300 different CF mutations."....
"We need global participation to advance as fast as possible.”